Hydroxychloroquine treatment for Alopecia Universalis: Report of six cases.
Hydroxychloroquine treatment for Alopecia Universalis: Report of six cases.
Australas J Dermatol. 2020 Jul 07;:
Authors: Akdogan N, Ersoy-Evans S
Abstract
Recent reports indicate that hydroxychloroquine is a potential new treatment option for alopecia universalis; thus, we aimed to report on the safety and efficacy of hydroxychloroquine in 6 patients with refractory alopecia universalis that were treated with 400 mg/d continuously for ≥6 months. The treatment outcome was retrospectively evaluated using the Severity of Alopecia Tool (SALT), and at the end of 6 months, patients with a ≥50% decrease in the SALT score were considered as strong responders, a 5%-50% decrease as intermediate responders and a <5% decrease as non-responders. The present findings indicate that hydroxychloroquine is not an effective treatment since in 5 of the 6 patients it was discontinued at the end of 6 months due to lack of hair regrowth, whereas only a 6-year-old boy responded with a SALT score change of 8% after the 12th month.
PMID: 32638352 [PubMed - as supplied by publisher]
Source: The Australasian Journal of Dermatology - Category: Dermatology Authors: Akdogan N, Ersoy-Evans S Tags: Australas J Dermatol Source Type: research
More News: Alopecia | Alopecia Universalis | Dermatology | Hydroxychloroquine | Skin | Sodium Chloride